tirzepatide suicidal ideation not linked to increased risk for depression Kaplan-Meier chart evaluating the risk

Originally developed to treat type 2 diabetes, tirzepatide has also shown significant efficacy in weight management, making it a valuable tool in the fight against obesity

Its ability to model organ crosstalk and capture genotype-specific drug responses underscores its potential to guide precision oncology

repeated freezing and thawing are not advised

Once denatured, the peptide cannot refold correctly and loses its biological activity

If tolerated and under the supervision of your prescriber, your dose may be increased to 5mg weekly then after a further four weeks, it may be increased by another 2.5mg up to a maximum dose of 15 mg once weekly

Report severe abdominal pain, persistent vomiting, or signs of dehydration to your healthcare provider immediately